Banque Cantonale Vaudoise Decreases Stock Position in Cencora, Inc. $COR

Banque Cantonale Vaudoise decreased its position in shares of Cencora, Inc. (NYSE:COR) by 34.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 9,374 shares of the company’s stock after selling 5,036 shares during the period. Banque Cantonale Vaudoise’s holdings in Cencora were worth $2,944,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. acquired a new stake in shares of Cencora during the fourth quarter valued at about $25,000. Oakworth Capital Inc. purchased a new stake in shares of Cencora during the fourth quarter worth about $26,000. Elyxium Wealth LLC acquired a new position in shares of Cencora in the fourth quarter worth about $27,000. Archer Investment Corp lifted its stake in shares of Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC purchased a new position in Cencora in the fourth quarter valued at about $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on COR shares. UBS Group raised their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Evercore set a $360.00 target price on Cencora in a research note on Wednesday, April 8th. Morgan Stanley set a $342.00 price target on shares of Cencora in a research report on Friday, May 8th. Finally, Weiss Ratings lowered shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $367.75.

Insider Buying and Selling at Cencora

In other Cencora news, Director Lauren M. Tyler bought 550 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were bought at an average cost of $270.23 per share, with a total value of $148,626.50. Following the completion of the acquisition, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.38% of the company’s stock.

Cencora Trading Up 1.1%

NYSE:COR opened at $287.55 on Friday. The company has a market cap of $55.95 billion, a PE ratio of 22.05, a P/E/G ratio of 1.53 and a beta of 0.59. The business’s 50 day moving average is $281.44 and its two-hundred day moving average is $322.43. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54.

Cencora (NYSE:COR) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. Cencora’s revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the firm posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, analysts predict that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s payout ratio is presently 18.40%.

Cencora announced that its board has authorized a stock repurchase program on Thursday, May 21st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to buy up to 3.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.